+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

All Ages
All Genders
Healthy Volunteers
ID00500123

Study of Genetic Testing and Outcomes for People at Risk of Alpha-1 Antitrypsin Deficiency Using Home Fingerstick Testing

Led by University of Florida · Updated on 2025-11-24

50000

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are studying genetic testing and outcomes in people who may have alpha-1 antitrypsin deficiency, a condition that can affect the lungs and liver. This study looks at the reasons why testing is done, the characteristics of those tested, and other health issues related to the condition. It uses a secure method where test results are sent confidentially by mail to protect privacy. The study involves home fingerstick testing to check for the alpha-1 antitrypsin genotype. Participants provide samples from home, which allows for easier access and privacy. This observational study gathers information about participants experiences and outcomes related to genetic testing without providing treatment. Participants will complete questionnaires before and after testing to share their views on the risks and benefits of genetic testing. The study collects data confidentially and monitors participant responses over time. It aims to better understand testing impacts and related health conditions. Participation duration varies, and study-related procedures are done remotely through mailed kits and surveys.

CONDITIONS

Brief Title

The Alpha-1 Foundation's and University of Florida's Alpha-1 Coded Testing (ACT) Study

Research Team

M

Michelle Owens, RN, BSN

A

Allison Faunce, B.A.

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here